Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 5 | 2026 | 313 | 1.980 |
Why?
|
| Astrocytoma | 2 | 2025 | 37 | 1.110 |
Why?
|
| Glioma | 2 | 2025 | 122 | 1.020 |
Why?
|
| Receptor, trkB | 1 | 2025 | 9 | 0.930 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2025 | 16 | 0.930 |
Why?
|
| Pyrazoles | 1 | 2025 | 80 | 0.890 |
Why?
|
| Pyrimidines | 1 | 2025 | 128 | 0.860 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 166 | 0.840 |
Why?
|
| Neurosurgical Procedures | 4 | 2026 | 231 | 0.760 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 686 | 0.620 |
Why?
|
| Child | 11 | 2026 | 2335 | 0.590 |
Why?
|
| Muscle Spasticity | 1 | 2018 | 3 | 0.570 |
Why?
|
| Upper Extremity | 1 | 2018 | 31 | 0.570 |
Why?
|
| Hydrocephalus | 2 | 2026 | 55 | 0.430 |
Why?
|
| Neurosurgery | 2 | 2023 | 76 | 0.370 |
Why?
|
| Infant | 5 | 2026 | 1056 | 0.340 |
Why?
|
| Child, Preschool | 5 | 2026 | 1201 | 0.340 |
Why?
|
| Humans | 13 | 2026 | 29078 | 0.250 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2026 | 19 | 0.240 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2025 | 348 | 0.230 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 25 | 0.230 |
Why?
|
| Meningeal Neoplasms | 1 | 2026 | 76 | 0.230 |
Why?
|
| Meningioma | 1 | 2026 | 82 | 0.230 |
Why?
|
| Adolescent | 4 | 2026 | 3233 | 0.230 |
Why?
|
| Reoperation | 1 | 2026 | 159 | 0.230 |
Why?
|
| Databases, Factual | 1 | 2026 | 271 | 0.220 |
Why?
|
| Hypoxia | 1 | 2025 | 90 | 0.220 |
Why?
|
| Membrane Glycoproteins | 1 | 2025 | 149 | 0.220 |
Why?
|
| Neovascularization, Pathologic | 1 | 2025 | 148 | 0.210 |
Why?
|
| Ventriculostomy | 1 | 2024 | 9 | 0.210 |
Why?
|
| Third Ventricle | 1 | 2024 | 9 | 0.210 |
Why?
|
| Female | 6 | 2026 | 15740 | 0.210 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2024 | 26 | 0.210 |
Why?
|
| Registries | 1 | 2026 | 398 | 0.210 |
Why?
|
| Postoperative Complications | 2 | 2026 | 639 | 0.190 |
Why?
|
| Mucormycosis | 1 | 2022 | 6 | 0.190 |
Why?
|
| Leukemia | 1 | 2022 | 30 | 0.180 |
Why?
|
| Young Adult | 2 | 2026 | 2855 | 0.170 |
Why?
|
| Male | 5 | 2026 | 14049 | 0.150 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2018 | 10 | 0.140 |
Why?
|
| Baclofen | 1 | 2018 | 8 | 0.140 |
Why?
|
| Muscle Relaxants, Central | 1 | 2018 | 11 | 0.140 |
Why?
|
| Odontoid Process | 1 | 2018 | 13 | 0.140 |
Why?
|
| Atlanto-Axial Joint | 1 | 2018 | 16 | 0.140 |
Why?
|
| Functional Laterality | 1 | 2018 | 64 | 0.140 |
Why?
|
| Cervical Vertebrae | 1 | 2018 | 123 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2026 | 2651 | 0.100 |
Why?
|
| Aging | 1 | 2018 | 1029 | 0.080 |
Why?
|
| World Health Organization | 1 | 2026 | 16 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2026 | 25 | 0.060 |
Why?
|
| Neoplasm Grading | 1 | 2026 | 108 | 0.060 |
Why?
|
| Consensus | 1 | 2026 | 76 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 59 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2025 | 165 | 0.050 |
Why?
|
| Neuroendoscopy | 1 | 2024 | 14 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2025 | 179 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2024 | 76 | 0.050 |
Why?
|
| Prognosis | 1 | 2026 | 815 | 0.050 |
Why?
|
| Reference Standards | 1 | 2023 | 57 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2023 | 35 | 0.050 |
Why?
|
| Chromosome Aberrations | 1 | 2023 | 37 | 0.050 |
Why?
|
| Heterografts | 1 | 2023 | 66 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2026 | 1033 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 33 | 0.050 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2023 | 14 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2023 | 32 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 136 | 0.050 |
Why?
|
| Triazoles | 1 | 2022 | 16 | 0.050 |
Why?
|
| Nitriles | 1 | 2022 | 38 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2022 | 37 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2023 | 108 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2023 | 108 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2022 | 69 | 0.040 |
Why?
|
| Proteomics | 1 | 2023 | 197 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 285 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2023 | 486 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2026 | 2430 | 0.040 |
Why?
|
| Mutation | 1 | 2023 | 873 | 0.040 |
Why?
|
| Reference Values | 1 | 2018 | 200 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 482 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 924 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 1009 | 0.030 |
Why?
|
| Animals | 1 | 2025 | 10756 | 0.020 |
Why?
|